News Agency
Men's Weekly

Karyopharm and Menarini Group Receive Full Marketing Authorization from the UK Medicines Healthcare Products Regulatory Agency for NEXPOVIO® (selinexor) in Combination with Bortezomib and Dexamethasone for the Treatment of Adult Patients with Mult

  • Written by PR Newswire
Karyopharm and Menarini Group Receive Full Marketing Authorization from the UK Medicines Healthcare Products Regulatory Agency for NEXPOVIO® (selinexor) in Combination with Bortezomib and Dexamethasone for the Treatment of Adult Patients with Mult

– Based on Results from Phase 3 BOSTON Study, Marketing Authorization Expands Multiple Myeloma Indication –

NEWTON, Mass. and FLORENCE, Italy, Feb. 21, 2023 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, and the Menarini Group...

Read more: Karyopharm and Menarini Group Receive Full Marketing Authorization from the UK Medicines...

How a Shopify Web Developer Can Make or Break Your eCommerce Store

Launching an online store today is easier than ever — but building one that actually performs well, drives traffic, and converts visitors into loyal customers is a different story. While Shopify offers a beginner-friendly interface, if you want to build... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion